.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Covington
Novartis
Merck
US Army
Cantor Fitzgerald
Healthtrust
Cerilliant
Medtronic

Generated: February 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 06023961

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi-aventis UsADLYXINlixisenatideSOLUTION;SUBCUTANEOUS208471-001Jul 27, 2016RXYesYes➤ Sign Up➤ Sign UpYIMPROVEMENT IN GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS BY USE OF A PEN INJECTOR
Sanofi-aventis UsADLYXINlixisenatideSOLUTION;SUBCUTANEOUS208471-002Jul 27, 2016RXYesYes➤ Sign Up➤ Sign UpYIMPROVEMENT IN GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS BY USE OF A PEN INJECTOR
Sanofi-aventis UsADLYXINlixisenatideSOLUTION;SUBCUTANEOUS208471-001Jul 27, 2016RXYesYes➤ Sign Up➤ Sign UpYIMPROVEMENT IN GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS BY USE OF A PEN INJECTOR
Sanofi-aventis UsADLYXINlixisenatideSOLUTION;SUBCUTANEOUS208471-002Jul 27, 2016RXYesYes➤ Sign Up➤ Sign UpYIMPROVEMENT IN GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS BY USE OF A PEN INJECTOR
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist